Device Trial Radar · NCT07571473
CoreSys Monitoring for Intraoperative Stress Management in Abdominal Hysterectomy
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Jan 8, 2025
Primary completion
Mar 31, 2027
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- Hospital Provincial de RosarioAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Coresys Health
- First posted
- May 6, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized controlled trial evaluates whether intraoperative guidance using the CoreSys monitor reduces the surgical stress response in patients undergoing elective open abdominal hysterectomy. Surgical stress involves complex hemodynamic, endocrine, and inflammatory responses that may negatively impact postoperative recovery. Patients will be randomized to either anesthesia guided by conventional clinical and hemodynamic parameters or anesthesia additionally guided by CoreSys-derived indices of consciousness, nociception, and stress activity. The primary objective is to assess whether CoreSys-guided anesthesia attenuates stress biomarkers, including interleukin-6 (IL-6), cortisol and glycemia.
Conditions
- Surgical Stress Response
- Inflammation
- Anesthesia
- Perioperative Care
Interventions
propofolDrug
Intravenous administration of propofol using target-controlled infusion (TCI) based on the Marsh pharmacokinetic model for induction and maintenance of general anesthesia.
CoreSys MonitorDevice
A non-invasive monitoring device that integrates electroencephalographic and autonomic signals to assess hypnotic level, nociception, and intraoperative stress indices.
Remifentanil (Target-Controlled Infusion)Drug
Intravenous administration of remifentanil using target-controlled infusion (TCI) based on the Minto pharmacokinetic model for intraoperative analgesia.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in interleukin-6 (IL-6) levelsTime frame: Baseline (pre-induction), end of surgery, and 24 hours postoperatively
- Change in cortisol levelsTime frame: Baseline (pre-induction), end of surgery, and 24 hours postoperatively
- Change in blood glucose levelsTime frame: Baseline (pre-induction), end of surgery, and 24 hours postoperatively
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital Provincial de Rosario
Rosario, Santa Fe Province, Argentina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.